2HELPS2B Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–0
- Moderate Risk1–1
- High Risk2–2
- Very High Risk3–3
The 2HELPS2B Score calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include seizure history. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates seizure risk in acutely ill patients undergoing continuous EEG (cEEG). Combines clinical factors and EEG findings to guide appropriate monitoring duration.
Clinical Indication
The 2HELPS2B Score is indicated for bedside clinical practice to support Estimates seizure risk in acutely ill patients undergoing continuous EEG (cEEG). Combines clinical factors and EEG findings to guide appropriate monitoring duration.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.
2HELPS2B = (Seizure history: 1 point if present) + (Epileptiform discharges: 1 point if present) + (LPDs: 1 point if present) + (BIPDs: 1 point if present) + (BIRDs: 1 point if present) + (Burst-suppression: 1 point if present)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| seizure_history | string | Yes | History of seizures (remote or recent acute suspected) |
| epileptiform_discharges | string | Yes | Epileptiform discharges (spikes or sporadic sharp waves) |
| lateralized_periodic_discharges | string | Yes | Lateralized periodic discharges (LPDs) |
| bilateral_independent_periodic_discharges | string | Yes | Bilateral independent periodic discharges (BIPDs) |
| brief_potentially_ictal_rhythmic_discharges | string | Yes | Brief potentially ictal rhythmic discharges (BIRDs) |
| burst_suppression | string | Yes | Burst-suppression pattern on EEG |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low Risk | Very low seizure risk |
| 1–1 | Moderate Risk | Moderate seizure risk |
| 2–2 | High Risk | High seizure risk |
| 3–3 | Very High Risk | Very high seizure risk |
| 4–4 | Extreme Risk | Extremely high seizure risk |
| 5–5 | Critical Risk | Critical seizure risk |
| 6–6 | Maximum Risk | Maximum seizure risk |
Evidence-Based References (EBM)
- Struck AF, Ustun B, Ruiz AR, et al. Association of an electroencephalography-based risk score with seizure probability in hospitalized patients. JAMA Neurol. 2017;74(12):1419-1424.
- Struck AF, Osman G, Rampal N, et al. Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram. Ann Neurol. 2017;82(4):177-185.
- Gaspard N, Foreman BP, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498-1503.